Related Experiment Video
Updated: Jun 29, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Cryptococcosis and Cryptococcal Meningitis: A Narrative Review and the Up-to-Date Management Approach
Zaheer A Qureshi1, Haider Ghazanfar2, Faryal Altaf2
1Medicine, Frank H. Netter MD School of Medicine, Quinnipiac University, Bridgeport, USA.
Cryptococcosis, a severe fungal infection, has limited treatment options and drug resistance is common. This review summarizes current and emerging therapies for cryptococcal meningitis, emphasizing the need for further research.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Cryptococcosis is a significant global fungal infection, with cryptococcal meningitis being its most severe form.
- Untreated cryptococcal meningitis is often fatal, and even treated patients can develop resistance or require prolonged therapy, especially those with AIDS.
- The subacute presentation of cryptococcal meningitis can complicate early diagnosis.
Purpose of the Study:
- To provide an evidence-based summary of current treatment modalities for cryptococcosis.
- To review emerging and investigational therapies for cryptococcal meningitis.
- To evaluate current management and empiric treatment strategies for cryptococcal meningitis.
Main Methods:
- This study is a narrative review of existing literature on cryptococcosis treatment.
- It summarizes data on established treatments and evaluates newer agents in clinical trials.
- The review also assesses diagnostic and management approaches for cryptococcal meningitis.
Main Results:
- Current treatment options for cryptococcosis are limited.
- Drug resistance and treatment failure are significant challenges in managing cryptococcal meningitis.
- Several novel therapeutic agents (18B7, T-2307, VT-1598, AR12, manogepix, and miltefosine) are under investigation.
Conclusions:
- There is a critical need for more effective and accessible treatments for cryptococcosis.
- Further research and clinical trials are essential to address the limitations of current therapeutic options.
- Improved diagnostic and management strategies are required for better patient outcomes.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Cystic Fibrosis: Management
Sinus disease and chronic...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

